We haven't progressed much in the federal system either. We have good labs that collect good data. We have some community labs, private labs, that publish resistance rates, like LifeLabs in Ontario, but we don't have a national clearing house, which should also have local data, because we can't use just national data. You need local data, because there are differences. Brampton, for example, has way more drug-resistant pathogens in hospital patients than Brandon does.
On November 7th, 2017. See this statement in context.